524412 logo

Aarey Drugs & Pharmaceuticals Limited Stock Price

BSE:524412 Community·₹2.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

524412 Share Price Performance

₹76.43
14.06 (22.54%)
₹76.43
14.06 (22.54%)
Price ₹76.43

524412 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and slightly overvalued.

2 Risks
1 Reward

Aarey Drugs & Pharmaceuticals Limited Key Details

₹4.3b

Revenue

₹4.2b

Cost of Revenue

₹103.2m

Gross Profit

₹67.3m

Other Expenses

₹35.8m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
1.28
2.41%
0.84%
38.3%
View Full Analysis

About 524412

Founded
1990
Employees
n/a
CEO
Mihir Ghatalia
WebsiteView website
www.aareydrugs.com

Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl, mefenamic acid, and doxofylline. In addition, the company trades chemicals and solvents, including aromatic chemicals, chemical acids, chlor-alkali, glycols and glycol ethers, fiber intermediates, and acetates and esters, as well as industrial alcohols, ketones, amines, oleochemicals, intermediates, olefins, phosphates, fertilizers, monomers, and chemicals. It serves pharmaceutical formulation manufacturers and pharmaceutical merchant exporters. Aarey Drugs & Pharmaceuticals Limited was incorporated in 1990 and is headquartered in Mumbai, India.

Recent 524412 News & Updates

Recent updates

No updates